Identification of functional platelet-activating factor receptors in Raji lymphoblasts

Jeffrey Travers, Q. Li, D. A. Kniss, R. H. Fertel

Research output: Contribution to journalArticle

32 Citations (Scopus)

Abstract

The binding and metabolism of platelet-activating factor (PAF) were characterized in Raji, a human Burkitt's lymphoma-derived cell line. Raji lymphoblasts readily metabolized PAF by deacetylation-reacylation at 37°C, but not at 4°C. Binding studies conducted at 4°C demonstrated specific binding that reacted saturation within 80 min. This binding was only partially reversible. Scatchard analysis of PAF binding data revealed a single class of PAF binding sites (17,800 ± 3,600/cell) with a K of 2.3 ± 0.3 nM. These high-affinity PAF binding sites were shown to be functional receptors, as 100 pm to 1 μM PAF increased free intracellular calcium in a dose-dependent manner. The dose of PAF necessary to achieve half maximal calcium mobilization response was 6.3 nM, which was in the range of the K for the receptor calculated from the binding studies. The structurally dissimilar PAF receptor antagonists CV-3988 and BN52021 inhibited the PAF-induced calcium changes at doses that competed with PAF binding. These studies provide the first evidence for a functional PAF receptor expressed on a lymphocyte cell line.

Original languageEnglish (US)
Pages (from-to)3708-3713
Number of pages6
JournalJournal of Immunology
Volume143
Issue number11
StatePublished - 1989
Externally publishedYes

Fingerprint

Platelet Activating Factor
Calcium
Binding Sites
platelet activating factor receptor
Cell Line
Burkitt Lymphoma
Lymphocytes

ASJC Scopus subject areas

  • Immunology

Cite this

Identification of functional platelet-activating factor receptors in Raji lymphoblasts. / Travers, Jeffrey; Li, Q.; Kniss, D. A.; Fertel, R. H.

In: Journal of Immunology, Vol. 143, No. 11, 1989, p. 3708-3713.

Research output: Contribution to journalArticle

Travers, Jeffrey ; Li, Q. ; Kniss, D. A. ; Fertel, R. H. / Identification of functional platelet-activating factor receptors in Raji lymphoblasts. In: Journal of Immunology. 1989 ; Vol. 143, No. 11. pp. 3708-3713.
@article{8fc5b41ea1324ffdbb156fb0f679acb7,
title = "Identification of functional platelet-activating factor receptors in Raji lymphoblasts",
abstract = "The binding and metabolism of platelet-activating factor (PAF) were characterized in Raji, a human Burkitt's lymphoma-derived cell line. Raji lymphoblasts readily metabolized PAF by deacetylation-reacylation at 37°C, but not at 4°C. Binding studies conducted at 4°C demonstrated specific binding that reacted saturation within 80 min. This binding was only partially reversible. Scatchard analysis of PAF binding data revealed a single class of PAF binding sites (17,800 ± 3,600/cell) with a K of 2.3 ± 0.3 nM. These high-affinity PAF binding sites were shown to be functional receptors, as 100 pm to 1 μM PAF increased free intracellular calcium in a dose-dependent manner. The dose of PAF necessary to achieve half maximal calcium mobilization response was 6.3 nM, which was in the range of the K for the receptor calculated from the binding studies. The structurally dissimilar PAF receptor antagonists CV-3988 and BN52021 inhibited the PAF-induced calcium changes at doses that competed with PAF binding. These studies provide the first evidence for a functional PAF receptor expressed on a lymphocyte cell line.",
author = "Jeffrey Travers and Q. Li and Kniss, {D. A.} and Fertel, {R. H.}",
year = "1989",
language = "English (US)",
volume = "143",
pages = "3708--3713",
journal = "Journal of Immunology",
issn = "0022-1767",
publisher = "American Association of Immunologists",
number = "11",

}

TY - JOUR

T1 - Identification of functional platelet-activating factor receptors in Raji lymphoblasts

AU - Travers, Jeffrey

AU - Li, Q.

AU - Kniss, D. A.

AU - Fertel, R. H.

PY - 1989

Y1 - 1989

N2 - The binding and metabolism of platelet-activating factor (PAF) were characterized in Raji, a human Burkitt's lymphoma-derived cell line. Raji lymphoblasts readily metabolized PAF by deacetylation-reacylation at 37°C, but not at 4°C. Binding studies conducted at 4°C demonstrated specific binding that reacted saturation within 80 min. This binding was only partially reversible. Scatchard analysis of PAF binding data revealed a single class of PAF binding sites (17,800 ± 3,600/cell) with a K of 2.3 ± 0.3 nM. These high-affinity PAF binding sites were shown to be functional receptors, as 100 pm to 1 μM PAF increased free intracellular calcium in a dose-dependent manner. The dose of PAF necessary to achieve half maximal calcium mobilization response was 6.3 nM, which was in the range of the K for the receptor calculated from the binding studies. The structurally dissimilar PAF receptor antagonists CV-3988 and BN52021 inhibited the PAF-induced calcium changes at doses that competed with PAF binding. These studies provide the first evidence for a functional PAF receptor expressed on a lymphocyte cell line.

AB - The binding and metabolism of platelet-activating factor (PAF) were characterized in Raji, a human Burkitt's lymphoma-derived cell line. Raji lymphoblasts readily metabolized PAF by deacetylation-reacylation at 37°C, but not at 4°C. Binding studies conducted at 4°C demonstrated specific binding that reacted saturation within 80 min. This binding was only partially reversible. Scatchard analysis of PAF binding data revealed a single class of PAF binding sites (17,800 ± 3,600/cell) with a K of 2.3 ± 0.3 nM. These high-affinity PAF binding sites were shown to be functional receptors, as 100 pm to 1 μM PAF increased free intracellular calcium in a dose-dependent manner. The dose of PAF necessary to achieve half maximal calcium mobilization response was 6.3 nM, which was in the range of the K for the receptor calculated from the binding studies. The structurally dissimilar PAF receptor antagonists CV-3988 and BN52021 inhibited the PAF-induced calcium changes at doses that competed with PAF binding. These studies provide the first evidence for a functional PAF receptor expressed on a lymphocyte cell line.

UR - http://www.scopus.com/inward/record.url?scp=0024331405&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024331405&partnerID=8YFLogxK

M3 - Article

C2 - 2555416

AN - SCOPUS:0024331405

VL - 143

SP - 3708

EP - 3713

JO - Journal of Immunology

JF - Journal of Immunology

SN - 0022-1767

IS - 11

ER -